An Ultra low field (ULF) prototype magnetic resonance imaging (MRI) scanner that does not require heavy shielding and is much quieter than commercially available MRI scanners was developed by Wu et al in the University of Hong Kong. The prototype system described in Physics World has 0.055 Tesla permanent samarium-cobalt (SmCo) magnet with a 29x70 cm gantry for patient access. Costing an estimated $20,000 to build, it would be significantly less expensive that the MRI scanners in use today which cost between $1 and $3 million. The researchers hope that the ULF scanner, which can be plugged in a typical wall outlet, although it generates a magnetic field of a much lower strength than those produced by clinical MRI machines in use today might one day bring this valuable clinical tool to 70% of the world's population that does not have access to MRI imaging and thus improve global access to neuroimaging.
Tuesday, March 1, 2022
Tuesday, February 1, 2022
Risk Factors Associated with long Covid
Three new studies published in Cell, Nature and Gut found several risk factors that make patients prone in developing post acute sequelae Covid-19 (PASC) or long Covid.
Those are Asthma, the presence of antibodies associated with autoimmune conditions and unhealthy gut bacteria. Other risk factors were Type 2 diabetes and the detection of genetic material from SARS-CoV-2 in the blood, which means the virus escaped from the lungs and spread to other parts of the body. Another risk factor was reactivated Epstein-Barr, the virus that causes infectious mononucleosis and infects about 90% of the people but normally remains dormant afterward.
Detectability of the PASC factors with tests early in the disease will assist in the understanding of emergent chronic conditions and more important will suggest specific long Covid treatment strategies.
Saturday, January 1, 2022
Covid-19 Pandemic; four countries - four tales
United States
A country of 330 million reports nearly 55 million cases during the last two years and 825,000 deaths or 2485 deaths per million due to Covid-19. Sixty two percent of its population has been completely vaccinated and 21% has received a 3rd dose. Although the U.S. is the leader in the development of vaccines their acceptance by the population has been mixed mostly due to political and cultural reasons. In the past week the average daily cases per 100,000 people was 116 with the 14-day trend increasing.
Greece
A country of 10 million reports 1.1 million cases and 21,800 deaths or 2080 deaths per million. The country had very few cases and deaths in the first wave of the pandemic. This success story was due to a very strict lockdown. Its vaccination program with 65% of its population completely vaccinated and 30% having had their 3rd dose is above average in Europe. In the past week the average daily cases per 100,000 people was 195 with the 14-day trend increasing.
Taiwan
A country of 23 million instituted very good epidemiological measures since the beginning of the pandemic and reports only 17,000 cases that caused 848 deaths or 37 deaths per million. In Taiwan 68% of its people are completely vaccinated and 1% had the 3rd dose. The average daily cases per 100,000 people of the past week was 0.1 case with the 14-day trend increasing.
New Zealand
A country of 5 million had 13,000 cases and 44 deaths or 9 deaths per million. New Zealand enacted a very strong lockdown early in the pandemic and recently enacted a successful vaccination campaign with 78% of its people being fully vaccinated and with 7% having the 3rd dose. The average daily cases per 100,000 people in past week was 1.2 with the 14-day trend increasing.
Discussion
Since Covid-19 was first diagnosed in China approximately 2 years ago it has infected 290 million people worldwide and has caused 5.5 million deaths according to JHU. A total of nearly 9 billion doses of vaccines have been administered worldwide. Although we now know that vaccines are not totally effective in the prevention of the disease, vaccinated individuals are not as sick as the non-vaccinated ones and definitely save lives especially among elderly individuals. According to a recent study by WHO/ECDC nearly half a million lives have been saved in Europe alone in less than a year.
The country with the worst death toll is Peru with 6,000 deaths per million and the country that has fared the best is China with 3 deaths per million. The average daily cases in China per 100,000 people in past week was zero.
On Jan 1, 2021 the daily count of cases worldwide was 580,000 while on the first day of 2022 the number has surpassed the 1 million due to the latest mutation of the virus "omicron" which very transmissible.
In the last two years we learned that lockdowns work but they adversely economies therefore cannot continue for a long time. Social isolation is also effective but it affects adversely people's psychology. In spite of the worldwide upheaval the pandemic caused there were success stories such as the speedy development of vaccines. The development of mRNA vaccines especially is noteworthy as they will likely be used not only in the prevention of viral diseases but the treatment of other diseases such as cancer. Also several antiviral medications have been developed and approved for use in the treatment of patients with Covid.
Conclusion
The above mentioned advancements will be used in the prevention and control of diseases and will benefit the health of humans for many decades into the future. In closing, I will make a prediction from lessons learned from prior pandemics which usually last 3 years; thus 2022 will be the last year that Covid-19 will be classified as a pandemic becoming from an endemic disease instead one of several viral disease that afflict humans.
Wednesday, December 1, 2021
Stem Cell Therapy in type 1 Diabetes
A 64-year-old man in the U.S. is likely the first patient who was cured from type 1 diabetes. According to NYT, his body now controls its insulin and blood sugar levels following an infusion of insulin-producing cells grown from embryonic stem cells.
The only cure that has ever worked in patients with type 1 diabetes is either a pancreas transplant or a transplant of the the insulin producing islet cells, from a donor's pancreas. Because of a shortage of organs such an approach is not an answer for the vast majority of patients with the disease. The cells infused in this patient were procured from unused fertilised eggs from a fertility clinic. It took over 20 years and a team of 15 people to successfully convert stem cells into islet cells at a cost of about $50 million.
If this successful treatment can be replicated it will be a major advance in the history of transplantation and will provide hope to 1.5 million Americans who live with the disease.
Monday, November 1, 2021
Pig Kidney Successfully Transplanted in a Human Patient
An article in NYT reported that surgeons successfully transplanted a genetically altered kidney to a patient and found the organ worked normally. The kidney was attached to a patient who had suffered brain death and was maintained on a ventilator. The kidney's vessels were connected to the patient's femoral artery and vein and it lay outside the body while it was observed for 54 hours. During the nearly three day it was observed it functioned normally, making urine and the waste product creatinine 'almost immediately' according to Dr. Robert Montgomery, the director of N.Y.U. Langone Transplant Institute who performed the procedure in September 2021. This medical advance is the culmination of years of experimental work that started in the 60s and is a milestone in the quest to successful xenotransplantation which may help the lives of millions of patients around the world.
Friday, October 1, 2021
Coronary Artery Calcium Scoring to Guide Statin Therapy
A paper published in JAMA Cardiology reports on findings of a multicenter, population based, prospective study that included 1,688 participants aged 45 to 75 years with no baseline ASCVD (Atherosclerotic Vascular Disease) or diabetes who were at intermediate risk for ASCVD and with LDL levels of 70 mg/dl.
The authors found that among the participants with CAC scores of 0, the presence of risk-enhancing factors was not associated with overall ASCVD risk that was higher than the recommended treatment threshold for the initiation of statin therapy.
The results of this study support the use of CAC scoring as a tool in the evaluation of risk and to more accurately classify individuals with intermediate risk for ASCVD who might benefit from statin therapy.
In conclusion the use of CAC scoring was associated with significant improvements in the reclassification and discrimination of incident ASCVD.
Wednesday, September 1, 2021
Whole Lung Irradiation as a Novel Treatment for Covid-19 Pneumonia
A study published in ScienceDirect reports on a novel treatment of 25 patients with proven Covid-19 pneumonia. All patients diagnosis was proven with an RT-PCR test, had SpO2 less than 94% on room air and a respiratory frequency of less than 24 per minute. Patients were treated in accordance with standard Covid-19 guidelines and received a single fraction of low dose radiation therapy (LDRT) of 0.5 Gy to both lungs within 10 days of the onset of symptoms and/or 5 days of hospital admission.
LDRT was well tolerated by all patients. A significant improvement in oxygenation was noted. Demand for supplemental oxygen showed also a significant reduction in the post-RT period with 88% recovering completely with 10 days and being discharged from the hospital in 6 days. Three patients deteriorated and died.
The authors concluded that based on their initial experience, LDRT is a promising treatment in a select group of patients with moderate to severe Covid-19 pneumonia and should be further investigated by a larger series.